文献速递瓣膜病与结构性心脏病

新诊断重度主动脉瓣狭窄患者的症状、疾病严重程度与治疗现状

Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis.
PubMed 文献 · Heart · 2019-07-13

该前瞻性多国注册研究纳入9个欧洲国家23家三级医院的2171例超声心动图新诊断重度主动脉瓣狭窄患者,平均年龄77.9岁,80.3%有症状;尽管指南推荐,仅76.2%决定干预,无症状患者中36.3%无指征却换瓣,管理仍不理想。

要点

  • 多数重度AS患者诊断时已处疾病晚期,80.3%有症状。
  • 仅76.2%做出干预决定,与指南I类推荐存在差距。
  • 无症状患者中36.3%无指征者仍接受换瓣手术。

核心结论

  • 多数重度AS患者诊断时已处晚期,相当比例患者管理仍不理想。

研究设计与样本

  • 前瞻性、多中心、多国注册研究,纳入9个欧洲国家23家三级医院2171例超声心动图新诊断重度AS患者。

主要发现

  • 平均年龄77.9岁,女性48.0%;平均AVA 0.73 cm2,Vmax 4.3 m/s,平均跨瓣压差47.1 mm Hg。
  • 62.1%有左心室肥厚,27.3%射血分数<50%;EuroSCORE II为4.0,25.3%肌酐清除率<50 mL/min,3.2%射血分数<30%。
  • 80.3%有症状(呼吸困难91.0%、头晕30.2%、胸痛28.9%),症状患者较无症状者更年长且合并症更多。
  • 仅76.2%做出干预决定(经导管50.4%,外科换瓣25.8%);无症状患者中57.7%有I/IIa类指征者计划手术,36.3%无指征者仍换瓣。

关键数值与推荐

  • 重度AS超声标准:AVA<1 cm2、指数化AVA<0.6 cm2/m2、Vmax>4 m/s和/或平均跨瓣压差>40 mm Hg。
  • 欧洲心脏病学会2017瓣膜病指南I类推荐为干预依据。

临床怎么用

  • 新诊断重度AS应评估症状与指南指征,及时做出干预决策。
  • 避免对无指征的无症状患者行换瓣手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Contemporary data on patients with previously undiagnosed severe aortic stenosis (AS) are scarce. We aimed to address this gap by gathering data from consecutive patients diagnosed with severe AS on echocardiography. METHODS: This was a prospective, multicentre, multinational, registry in 23 tertiary care hospitals across 9 European countries. Patients with a diagnosis of severe AS were included using echocardiography (aortic valve area (AVA) <1 cm2, indexed AVA <0.6 cm2/m2, maximum jet-velocity (Vmax) >4 m/s and/or mean transvalvular gradient >40 mm Hg). RESULTS: The 2171 participants had a mean age of 77.9 years and 48.0% were female. The mean AVA was 0.73 cm2, Vmax4.3 m/s and mean gradient 47.1 mm Hg; 62.1% had left ventricular hypertrophy and 27.3% an ejection fraction (EF) <50%. 1743 patients (80.3%) were symptomatic (shortness-of-breath 91.0%; dizziness 30.2%, chest pain 28.9%). Patients had a EuroSCORE II of 4.0; 25.3% had a creatinine clearance <50 mL/min, and 3.2% had an EF <30%. Symptomatic patients were older and had more comorbidities than asymptomatic patients. Despite European Society of Cardiology 2017 valvular heart disease guideline class I recommendation, in only 76.2% a decision was made for an intervention (transcatheter 50.4%, surgical aortic valve replacement 25.8%). In asymptomatic patients, 57.7% with a class I/IIa indication were scheduled for a procedure, while 36.3% patients without an indication had their valve replaced. CONCLUSIONS: The majority of patients with severe AS presented at an advanced disease stage. Management of severe AS remained suboptimal in a significant proportion of contemporary patients with severe AS. TRIAL REGISTRATION NUMBER: NCT02241447;Results.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Frey N, Steeds RP, Rudolph TK, et al. Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis. Heart. 2019. PMID: 31302639. doi:10.1136/heartjnl-2019-314940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。